{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T16:43:45Z","timestamp":1789231425094,"version":"build-2803163510"},"reference-count":142,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T00:00:00Z","timestamp":1687824000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000345","name":"Association of Surgeons of Great Britain and Ireland","doi-asserted-by":"publisher","award":["P90797"],"award-info":[{"award-number":["P90797"]}],"id":[{"id":"10.13039\/501100000345","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018897","name":"Lions Medical Research Foundation","doi-asserted-by":"publisher","award":["P91847"],"award-info":[{"award-number":["P91847"]}],"id":[{"id":"10.13039\/501100018897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.jhepr.2023.100835","type":"journal-article","created":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T12:42:06Z","timestamp":1688042526000},"page":"100835","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["Non-alcoholic fatty liver disease in women \u2013 Current knowledge and emerging concepts"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4172-1344","authenticated-orcid":false,"given":"Pei Chia","family":"Eng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4746-7065","authenticated-orcid":false,"given":"Roberta","family":"Forlano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tricia","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinelopi","family":"Manousou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5950-4316","authenticated-orcid":false,"given":"Waljit S.","family":"Dhillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7599-0166","authenticated-orcid":false,"given":"Chioma","family":"Izzi-Engbeaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2023.100835_bib1","doi-asserted-by":"crossref","DOI":"10.1097\/TP.0000000000002480","article-title":"Nonalcoholic fatty liver disease: basic pathogenetic mechanisms in the progression from NAFLD to NASH","volume":"103","author":"Pierantonelli","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.jhepr.2023.100835_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/hep4.1479","article-title":"Pathogenesis of nonalcoholic steatohepatitis: an overview","volume":"4","author":"Parthasarathy","year":"2020","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhepr.2023.100835_bib3","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.2337\/db10-0224","article-title":"Adipose tissue dysfunction signals progression of hepatic steatosis towards nonalcoholic steatohepatitis in C57Bl\/6 mice","volume":"59","author":"Duval","year":"2010","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.jhepr.2023.100835_bib4","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s00018-019-03011-w","article-title":"The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD)","volume":"76","author":"Safari","year":"2019","journal-title":"Cellular Mol Life Sci"},{"key":"10.1016\/j.jhepr.2023.100835_bib5","article-title":"Fructose and NAFLD: the multifaceted aspects of fructose metabolism","volume":"9","author":"Jegatheesan","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.jhepr.2023.100835_bib6","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.aohep.2020.09.006","article-title":"Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease","volume":"19","author":"Arab","year":"2020","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jhepr.2023.100835_bib7","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100835_bib8","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","article-title":"Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016\u20132030","volume":"69","author":"Estes","year":"2018","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.jhepr.2023.100835_bib9","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1007\/s10620-016-4143-0","article-title":"Global epidemiology of nonalcoholic fatty liver disease and perspectives on US minority populations","volume":"61","author":"Sherif","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhepr.2023.100835_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease\u2014meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100835_bib11","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100835_bib12","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.jhep.2021.07.035","article-title":"Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States","volume":"75","author":"Kim","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2023.100835_bib13","doi-asserted-by":"crossref","first-page":"6","DOI":"10.14218\/JCTH.2021.00089","article-title":"Comparing the diagnostic criteria of MAFLD and NAFLD in the Chinese population: a population-based prospective cohort study","volume":"10","author":"Yu","year":"2022","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.jhepr.2023.100835_bib14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cgh.2020.04.067","article-title":"Women have lower risk of nonalcoholic fatty liver disease but higher risk of progression vs men: a systematic review and meta-analysis","volume":"19","author":"Balakrishnan","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100835_bib15","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/hep.31312","article-title":"Hepatic molecular signatures highlight the sexual dimorphism of nonalcoholic steatohepatitis (NASH)","volume":"73","author":"Vandel","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100835_bib16","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1210\/clinem\/dgaa175","article-title":"Plasma BCAA changes in patients with NAFLD are sex dependent","volume":"105","author":"Grzych","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jhepr.2023.100835_bib17","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1056\/NEJMoa2029349","article-title":"Prospective study of outcomes in adults with nonalcoholic fatty liver disease","volume":"385","author":"Sanyal","year":"2021","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jhepr.2023.100835_bib18","first-page":"10","article-title":"The Fatty liver Index (FLI) 15 years later: a reappraisal","volume":"1","author":"Lonardo","year":"2021","journal-title":"Metab Target Organ Damage"},{"key":"10.1016\/j.jhepr.2023.100835_bib19","first-page":"21","article-title":"AGILE 3+ score for the diagnosis of advanced fibrosis and for predicting liver-related events in NAFLD","author":"Pennisi","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100835_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12876-021-01978-0","article-title":"Hepatocellular carcinoma in nonalcoholic fatty liver disease with or without cirrhosis: a population-based study","volume":"21","author":"Pinyopornpanish","year":"2021","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100835_bib21","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1038\/s41395-018-0088-6","article-title":"NASH leading cause of liver transplant in women: updated analysis of indications for liver transplant and ethnic and gender variances","volume":"113","author":"Noureddin","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100835_bib22","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13297","article-title":"Gender disparities in liver transplant candidates with nonalcoholic steatohepatitis","volume":"32","author":"Loy","year":"2018","journal-title":"Clin Transpl"},{"key":"10.1016\/j.jhepr.2023.100835_bib24","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1001\/jamasurg.2022.1548","article-title":"Proposing a sex-adjusted sodium-adjusted MELD score for liver transplant allocation","volume":"157","author":"Sealock","year":"2022","journal-title":"JAMA Surg"},{"key":"10.1016\/j.jhepr.2023.100835_bib25","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/hep4.1285","article-title":"Prevalence of nonalcoholic fatty liver disease in the female population","volume":"3","author":"Arshad","year":"2019","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhepr.2023.100835_bib26","doi-asserted-by":"crossref","DOI":"10.14309\/ajg.0000000000000401","article-title":"Women with nonalcoholic fatty liver disease lose protection against cardiovascular disease: a longitudinal cohort study","volume":"114","author":"Allen","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100835_bib27","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1055\/s-0029-1202348","article-title":"Fatty acid oxidation is decreased in the liver of ovariectomized rats","volume":"41","author":"Paquette","year":"2009","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.jhepr.2023.100835_bib28","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1097\/gme.0b013e31817b8159","article-title":"Effects of ovariectomy on PPAR\u03b1, SREBP-1c, and SCD-1 gene expression in the rat liver","volume":"15","author":"Paquette","year":"2008","journal-title":"Menopause"},{"key":"10.1016\/j.jhepr.2023.100835_bib29","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.molmet.2019.12.009","article-title":"Hepatic ER\u03b1 accounts for sex differences in the ability to cope with an excess of dietary lipids","volume":"32","author":"Meda","year":"2020","journal-title":"Mol Metab"},{"key":"10.1016\/j.jhepr.2023.100835_bib30","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.mce.2013.07.007","article-title":"Molecular effects of ER alpha- and beta-selective agonists on regulation of energy homeostasis in obese female Wistar rats","volume":"377","author":"Weigt","year":"2013","journal-title":"Mol Cel Endocrinol"},{"key":"10.1016\/j.jhepr.2023.100835_bib31","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.gene.2014.02.036","article-title":"Sex- and age-dependent effects of Gpr30 genetic deletion on the metabolic and cardiovascular profiles of diet-induced obese mice","volume":"540","author":"Meoli","year":"2014","journal-title":"Gene"},{"key":"10.1016\/j.jhepr.2023.100835_bib32","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.molmet.2017.12.012","article-title":"Hepatocyte estrogen receptor alpha mediates estrogen action to promote reverse cholesterol transport during Western-type diet feeding","volume":"8","author":"Zhu","year":"2018","journal-title":"Mol Metab"},{"key":"10.1016\/j.jhepr.2023.100835_bib33","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3389\/fendo.2019.00589","article-title":"Menopausal status and physical activity are independently associated with cardiovascular risk factors of healthy middle-aged women: cross-sectional and longitudinal evidence","volume":"10","author":"Karvinen","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jhepr.2023.100835_bib34","doi-asserted-by":"crossref","first-page":"E818","DOI":"10.1097\/MEG.0000000000002269","article-title":"Glucagon is associated with NAFLD inflammatory progression in type 2 diabetes, not with NAFLD fibrotic progression","volume":"33","author":"Wang","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100835_bib35","doi-asserted-by":"crossref","DOI":"10.1152\/ajpendo.00492.2002","article-title":"Glucagon and regulation of glucose metabolism","volume":"284","author":"Jiang","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jhepr.2023.100835_bib36","article-title":"Glucagon-induced acetylation of energy-sensing factors in control of hepatic metabolism","volume":"20","author":"Zhang","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jhepr.2023.100835_bib37","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2362.1977.tb01595.x","article-title":"Mechanism of oestrogen and progesterone effects on lipid and carbohydrate metabolism: alteration in the insulin: glucagon molar ratio and hepatic enzyme activity","volume":"7","author":"Mandour","year":"1977","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jhepr.2023.100835_bib38","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1210\/en.2008-0623","article-title":"Deletion of the G protein-coupled receptor 30 impairs glucose tolerance, reduces bone growth, increases blood pressure, and eliminates estradiol-stimulated insulin release in female mice","volume":"150","author":"Martensson","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.jhepr.2023.100835_bib39","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/BF00297394","article-title":"Ovarian-adrenal interactions in regulation of endocrine pancreatic function in the rat","volume":"24","author":"Faure","year":"1983","journal-title":"Diabetologia"},{"key":"10.1016\/j.jhepr.2023.100835_bib40","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.steroids.2012.01.015","article-title":"Role of ER\u03b2 and GPR30 in the endocrine pancreas: a matter of estrogen dose","volume":"77","author":"Ropero","year":"2012","journal-title":"Steroids"},{"key":"10.1016\/j.jhepr.2023.100835_bib41","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1530\/JOE-15-0471","article-title":"Prenatal hyperandrogenism induces alterations that affect liver lipid metabolism","volume":"230","author":"Abruzzese","year":"2016","journal-title":"J Endocrinol"},{"key":"10.1016\/j.jhepr.2023.100835_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024877","article-title":"The in utero programming effect of increased maternal androgens and a direct fetal intervention on liver and metabolic function in adult sheep","volume":"6","author":"Hogg","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2023.100835_bib43","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1095\/biolreprod.114.120063","article-title":"High-fat diet induces significant metabolic disorders in a mouse model of polycystic ovary Syndrome","volume":"91","author":"Lai","year":"2014","journal-title":"Biol Reprod"},{"key":"10.1016\/j.jhepr.2023.100835_bib44","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1210\/en.2016-1553","article-title":"Low-dose dihydrotestosterone drives metabolic dysfunction via cytosolic and nuclear hepatic androgen receptor mechanisms","volume":"158","author":"Andrisse","year":"2017","journal-title":"Endocrinology"},{"key":"10.1016\/j.jhepr.2023.100835_bib45","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1210\/en.2014-1196","article-title":"Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models","volume":"155","author":"Caldwell","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.jhepr.2023.100835_bib46","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1530\/JOE-21-0040","article-title":"DHT causes liver steatosis via transcriptional regulation of SCAP in normal weight female mice","volume":"250","author":"Seidu","year":"2021","journal-title":"J Endocrinol"},{"key":"10.1016\/j.jhepr.2023.100835_bib47","doi-asserted-by":"crossref","first-page":"105829","DOI":"10.1016\/j.jsbmb.2021.105829","article-title":"Long-term androgen excess induces insulin resistance and non-alcoholic fatty liver disease in PCOS-like rats","volume":"208","author":"Cui","year":"2021","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.jhepr.2023.100835_bib48","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/oby.20950","article-title":"Earlier menarche is associated with fatty liver and abdominal ectopic fat in midlife, independent of young adult BMI: the CARDIA study","volume":"23","author":"Mueller","year":"2015","journal-title":"Obesity"},{"key":"10.1016\/j.jhepr.2023.100835_bib49","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/ajcn\/74.3.287","article-title":"Family social class, maternal body mass index, childhood body mass index, and age at menarche as predictors of adult obesity","volume":"74","author":"Laitinen","year":"2001","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jhepr.2023.100835_bib50","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1111\/jog.13093","article-title":"Duration of reproductive lifespan and age at menarche in relation to metabolic syndrome in postmenopausal Chinese women","volume":"42","author":"Cao","year":"2016","journal-title":"J\u00a0Obstet Gynaecol Res"},{"key":"10.1016\/j.jhepr.2023.100835_bib51","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1210\/endo.142.11.8547","article-title":"Minireview: aromatase and the regulation of estrogen biosynthesis\u2014some new perspectives","volume":"142","author":"Simpson","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.jhepr.2023.100835_bib52","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/GME.0000000000001463","article-title":"Systemic estradiol levels with low-dose vaginal estrogens","volume":"27","author":"Santen","year":"2020","journal-title":"Menopause"},{"key":"10.1016\/j.jhepr.2023.100835_bib53","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1210\/er.2004-0020","article-title":"Estrogen\u2014the good, the bad, and the unexpected","volume":"26","author":"Simpson","year":"2005","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jhepr.2023.100835_bib54","first-page":"1037","article-title":"Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosis","volume":"8","author":"Turola","year":"2015","journal-title":"DMM Dis Models Mech"},{"key":"10.1016\/j.jhepr.2023.100835_bib55","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1002\/hep.26761","article-title":"Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis","volume":"59","author":"Yang","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100835_bib56","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1002\/hep.27097","article-title":"The influence of menopause on the development of hepatic fibrosis in nonobese women with nonalcoholic fatty liver disease","volume":"60","author":"Yoneda","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100835_bib57","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s10654-019-00526-1","article-title":"Oophorectomy and risk of non-alcoholic fatty liver disease and primary liver cancer in the Clinical Practice Research Datalink","volume":"34","author":"Florio","year":"2019","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.jhepr.2023.100835_bib58","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/hep.28514","article-title":"A longer duration of estrogen deficiency increases fibrosis risk among postmenopausal women with nonalcoholic fatty liver disease","volume":"64","author":"Klair","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100835_bib59","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2265.2006.02543.x","article-title":"Effects of HRT on liver enzyme levels in women with type 2 diabetes: a randomized placebo-controlled trial","volume":"65","author":"McKenzie","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jhepr.2023.100835_bib60","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1665-2681(19)31502-9","article-title":"Hormone replacement therapy in menopausal women: risk factor or protection to nonalcoholic fatty liver disease?","volume":"11","author":"Florentino","year":"2012","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jhepr.2023.100835_bib61","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1590\/S0004-28032013000200032","article-title":"Nonalcoholic fatty liver disease in menopausal women","volume":"50","author":"Florentino","year":"2013","journal-title":"Arq Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100835_bib62","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3748\/wjg.v18.i3.237","article-title":"Aging is a risk factor of nonalcoholic fatty liver disease in premenopausal women","volume":"18","author":"Hamaguchi","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100835_bib63","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cgh.2016.07.034","article-title":"Patient sex, reproductive status, and synthetic hormone use associate with histologic severity of nonalcoholic steatohepatitis","volume":"15","author":"Yang","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100835_bib64","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1136\/bmj.38391.663287.E0","article-title":"Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial","volume":"330","author":"Bruno","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.jhepr.2023.100835_bib65","doi-asserted-by":"crossref","first-page":"4019","DOI":"10.3390\/ijms15034019","article-title":"The effect and mechanism of tamoxifen-induced hepatocyte steatosis in\u00a0vitro","volume":"15","author":"Zhao","year":"2014","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jhepr.2023.100835_bib66","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/toxres\/tfac043","article-title":"Tamoxifen induced hepatic steatosis in high-fat feeding rats through SIRT1-Foxo1 suppression and LXR-SREBP1c activation","volume":"11","author":"Li","year":"2022","journal-title":"Toxicol Res (Camb)"},{"key":"10.1016\/j.jhepr.2023.100835_bib67","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.2337\/db13-0282","article-title":"Prevention of obesity and insulin resistance by estrogens requires ER\u03b1 activation function-2 (ER\u03b1AF-2), whereas eraaf-1 is dispensable","volume":"62","author":"Handgraaf","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.jhepr.2023.100835_bib68","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-17-0430","article-title":"Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting","volume":"177","author":"Gravholt","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jhepr.2023.100835_bib69","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0895-4356(97)00237-0","article-title":"Morbidity in turner syndrome","volume":"51","author":"Gravholt","year":"1998","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jhepr.2023.100835_bib70","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/liv.12007","article-title":"Liver involvement in Turner syndrome","volume":"33","author":"Roulot","year":"2013","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2023.100835_bib71","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/cen.13811","article-title":"Liver biochemical abnormalities in Turner syndrome: a comprehensive characterization of an adult population","volume":"89","author":"Calanchini","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jhepr.2023.100835_bib72","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1210\/jc.2004-1966","article-title":"Adipokine dysregulation in turner syndrome: comparison of circulating interleukin-6 and leptin concentrations with measures of adiposity and C-reactive protein","volume":"90","author":"Ostberg","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jhepr.2023.100835_bib73","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1210\/jc.2004-1939","article-title":"Excess visceral and hepatic adipose tissue in turner syndrome determined by magnetic resonance imaging: estrogen deficiency associated with hepatic adipose content","volume":"90","author":"Ostberg","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jhepr.2023.100835_bib74","doi-asserted-by":"crossref","first-page":"74","DOI":"10.4161\/adip.23320","article-title":"Metabolic impact of sex chromosomes","volume":"2","author":"Link","year":"2013","journal-title":"Adipocyte"},{"key":"10.1016\/j.jhepr.2023.100835_bib75","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1210\/jc.2009-0384","article-title":"X-chromosome gene dosage and the risk of diabetes in Turner syndrome","volume":"94","author":"Bakalov","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jhepr.2023.100835_bib76","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1001\/jama.295.12.1373","article-title":"Maternal X chromosome, visceral adiposity, and lipid profile","volume":"295","author":"Van","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jhepr.2023.100835_bib77","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.fertnstert.2018.05.004","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"110","author":"Teede","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jhepr.2023.100835_bib78","article-title":"Prevalence, risk factors, and pathophysiology of nonalcoholic fatty liver disease (NAFLD) in women with polycystic ovary syndrome (PCOS)","volume":"10","author":"Ra\u0111enovi\u0107","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.jhepr.2023.100835_bib79","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002542","article-title":"Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: a longitudinal study based on a United Kingdom primary care database","volume":"15","author":"Kumarendran","year":"2018","journal-title":"Plos Med"},{"key":"10.1016\/j.jhepr.2023.100835_bib80","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1440-1746.2008.05740.x","article-title":"An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome","volume":"24","author":"Brzozowska","year":"2009","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100835_bib81","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1210\/jc.2012-1382","article-title":"Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance","volume":"97","author":"Jones","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jhepr.2023.100835_bib82","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/ijo.2017.116","article-title":"High-free androgen index is associated with increased risk of non-Alcoholic fatty liver disease in women with polycystic ovary syndrome, independent of obesity and insulin resistance","volume":"41","author":"Cai","year":"2017","journal-title":"Int J Obes"},{"key":"10.1016\/j.jhepr.2023.100835_bib83","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jhep.2014.11.002","article-title":"Circulating phospholipid profiling identifies portal contribution to NASH signature in obesity","volume":"62","author":"Anjani","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100835_bib84","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1210\/jc.2017-00947","article-title":"AKR1C3-Mediated adipose androgen generation drives lipotoxicity in women with polycystic ovary syndrome","volume":"102","author":"O\u2019Reilly","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jhepr.2023.100835_bib85","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1210\/jcem-54-2-254","article-title":"Relation of body fat distribution to metabolic complications of obesity","volume":"54","author":"Kissebah","year":"1982","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jhepr.2023.100835_bib86","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1467-789X.2009.00623.x","article-title":"Subcutaneous and visceral adipose tissue: structural and functional differences","volume":"11","author":"Ibrahim","year":"2010","journal-title":"Obes Rev"},{"key":"10.1016\/j.jhepr.2023.100835_bib87","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1152\/japplphysiol.01035.2007","article-title":"Femoral-gluteal subcutaneous and intermuscular adipose tissues have independent and opposing relationships with CVD risk","volume":"104","author":"Yim","year":"2008","journal-title":"J\u00a0Appl Physiol (1985)"},{"key":"10.1016\/j.jhepr.2023.100835_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2042-6410-3-13","article-title":"Sex differences in human adipose tissues - the biology of pear shape","volume":"3","author":"Karastergiou","year":"2012","journal-title":"Biol Sex Differ"},{"key":"10.1016\/j.jhepr.2023.100835_bib89","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15253","article-title":"Impact of fat mass and distribution on lipid turnover in human adipose tissue","volume":"8","author":"Spalding","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhepr.2023.100835_bib90","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jhepr.2019.07.002","article-title":"From NASH to diabetes and from diabetes to NASH: mechanisms and treatment options","volume":"1","author":"Gastaldelli","year":"2019","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2023.100835_bib91","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.2337\/db10-0483","article-title":"Intrinsic depot-specific differences in the secretome of adipose tissue, preadipocytes, and adipose tissue\u2013derived microvascular endothelial cells","volume":"59","author":"Hocking","year":"2010","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.jhepr.2023.100835_bib92","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s12325-017-0556-1","article-title":"NAFLD as a sexual dimorphic disease: role of gender and reproductive status in the development and progression of nonalcoholic fatty liver disease and inherent cardiovascular risk","volume":"34","author":"Ballestri","year":"2017","journal-title":"Adv Ther"},{"key":"10.1016\/j.jhepr.2023.100835_bib93","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.cgh.2015.07.024","article-title":"Body fat distribution and risk of incident and regressed nonalcoholic fatty liver disease","volume":"14","author":"Kim","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100835_bib94","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/ijo.2008.25","article-title":"Increased visceral fat and decreased energy expenditure during the menopausal transition","volume":"32","author":"Lovejoy","year":"2008","journal-title":"Int J Obes"},{"key":"10.1016\/j.jhepr.2023.100835_bib95","doi-asserted-by":"crossref","first-page":"14750","DOI":"10.1038\/s41598-021-94189-2","article-title":"Changes in abdominal subcutaneous adipose tissue phenotype following menopause is associated with increased visceral fat mass","volume":"11","author":"Abildgaard","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2023.100835_bib96","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.1210\/jc.2001-012034","article-title":"Differences in adipose tissue metabolism between postmenopausal and perimenopausal women","volume":"87","author":"Ferrara","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jhepr.2023.100835_bib97","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1038\/oby.2008.326","article-title":"Subcutaneous abdominal adipose tissue subcompartments: potential role in rosiglitazone effects","volume":"16","author":"Walker","year":"2008","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.jhepr.2023.100835_bib98","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.fertnstert.2006.02.085","article-title":"Estrogen and exercise may be related to body fat distribution and leptin in young women","volume":"86","author":"Puder","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jhepr.2023.100835_bib99","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1210\/en.2008-0971","article-title":"Estrogens protect against high-fat diet-induced insulin resistance and glucose intolerance in mice","volume":"150","author":"Riant","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.jhepr.2023.100835_bib100","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJM199304153281501","article-title":"Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women","volume":"328","author":"Nabulsi","year":"1993","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.jhepr.2023.100835_bib101","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1038\/ijo.2015.102","article-title":"Estrogens protect male mice from obesity complications and influence glucocorticoid metabolism","volume":"39","author":"Dakin","year":"2015","journal-title":"Int J Obes"},{"key":"10.1016\/j.jhepr.2023.100835_bib102","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s12072-019-09999-4","article-title":"Sarcopenia: an emerging risk factor for non-alcoholic fatty liver disease","volume":"14","author":"Lee","year":"2020","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhepr.2023.100835_bib103","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4103\/sjg.SJG_237_17","article-title":"Sarcopenia and risk of nonalcoholic fatty liver disease: a meta-analysis","volume":"24","author":"Wijarnpreecha","year":"2018","journal-title":"Saudi J Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100835_bib104","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jhep.2016.08.019","article-title":"Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis","volume":"66","author":"Koo","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100835_bib105","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/jcsm.12719","article-title":"Non-alcoholic fatty liver disease and sarcopenia additively increase mortality: a Korean nationwide survey","volume":"12","author":"Moon","year":"2021","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.jhepr.2023.100835_bib106","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3803\/EnM.2020.405","article-title":"Sarcopenia and muscle aging: a brief overview","volume":"35","author":"Dao","year":"2020","journal-title":"Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.jhepr.2023.100835_bib107","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrendo.2012.49","article-title":"Muscles, exercise and obesity: skeletal muscle as a secretory organ","volume":"8","author":"Pedersen","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jhepr.2023.100835_bib108","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.1113\/JP271212","article-title":"The ageing neuromuscular system and sarcopenia: a mitochondrial perspective","volume":"594","author":"Rygiel","year":"2016","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.jhepr.2023.100835_bib109","first-page":"11","article-title":"SIRT1 promotes lipid metabolism and mitochondrial biogenesis in adipocytes and coordinates adipogenesis by targeting key enzymatic pathways","author":"Majeed","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2023.100835_bib110","article-title":"Myosteatosis, but not sarcopenia, predisposes NAFLD subjects to early steatohepatitis and fibrosis progression","author":"Hsieh","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100835_bib111","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jhep.2021.02.037","article-title":"Muscle fat content is strongly associated with NASH: a longitudinal study in patients with morbid obesity","volume":"75","author":"Nachit","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100835_bib112","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.774030","article-title":"Impact of sarcopenia on the severity of the liver damage in patients with non-alcoholic fatty liver disease","volume":"8","author":"Zambon Azevedo","year":"2022","journal-title":"Front Nutr"},{"key":"10.1016\/j.jhepr.2023.100835_bib118","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1007\/s10620-013-2740-8","article-title":"Identifying practice gaps to optimize medical care for patients with nonalcoholic fatty liver disease","volume":"58","author":"Wieland","year":"2013","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhepr.2023.100835_bib119","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jhep.2021.10.025","article-title":"The global NAFLD policy review and preparedness index: are countries ready to address this silent public health challenge?","volume":"76","author":"Lazarus","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100835_bib120","series-title":"Clinical practice guidelines EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease","year":"2016"},{"key":"10.1016\/j.jhepr.2023.100835_bib121","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.gastre.2018.05.013","article-title":"Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline","volume":"41","author":"Aller","year":"2018","journal-title":"Gastroenterolog\u00eda y Hepatolog\u00eda (English Edition)"},{"key":"10.1016\/j.jhepr.2023.100835_bib122","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/jgh.13856","article-title":"The Asia\u2013Pacific working party on non-alcoholic fatty liver disease guidelines 2017\u2014Part 2: management and special groups","volume":"33","author":"Chitturi","year":"2018","journal-title":"J Gastroenterol Hepatol (Australia)"},{"key":"10.1016\/j.jhepr.2023.100835_bib123","series-title":"Non-alcoholic fatty liver disease (NAFLD): assessment and management NICE guideline","first-page":"1","year":"2016"},{"key":"10.1016\/j.jhepr.2023.100835_bib124","series-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American association for the study of liver diseases","author":"Chalasani","year":"2017"},{"key":"10.1016\/j.jhepr.2023.100835_bib125","unstructured":"Clinical Assessment and Management of Nonalcoholic Fatty Liver Disease | AASLD. https:\/\/www.aasld.org\/practice-guidelines\/clinical-assessment-and-management-nonalcoholic-fatty-liver-disease (accessed April 3, 2023)."},{"key":"10.1016\/j.jhepr.2023.100835_bib126","doi-asserted-by":"crossref","first-page":"5803","DOI":"10.3748\/wjg.v27.i35.5803","article-title":"Screening for nonalcoholic fatty liver disease-when, who and how?","volume":"27","author":"Dietrich","year":"2021","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100835_bib127","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/hep.29489","article-title":"Performance characteristics of vibration-controlled transient elastography for evaluation of nonalcoholic fatty liver disease","volume":"67","author":"Vuppalanchi","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100835_bib128","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.cgh.2017.11.026","article-title":"Nonalcoholic fatty liver disease associates with increased overall mortality and death from cancer, cardiovascular disease, and liver disease in women but not men","volume":"16","author":"Hwang","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100835_bib129","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1002\/hep4.1419","article-title":"Mortality related to nonalcoholic fatty liver disease is increasing in the United States","volume":"3","author":"Paik","year":"2019","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhepr.2023.100835_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2021.100556","article-title":"Causes of death in patients with Non-alcoholic Fatty Liver Disease (NAFLD), alcoholic liver disease and chronic viral Hepatitis B and C","volume":"27","author":"Golabi","year":"2022","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jhepr.2023.100835_bib131","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2741\/4892","article-title":"Current treatment paradigms and emerging therapies for NAFLD\/NASH","volume":"26","author":"Raza","year":"2021","journal-title":"Front Biosci (Landmark Ed"},{"key":"10.1016\/j.jhepr.2023.100835_bib132","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis","volume":"149","author":"Vilar-Gomez","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2023.100835_bib133","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.33457","article-title":"Effect of bimagrumab vs placebo on body fat mass among adults with type 2 diabetes and obesity: a phase 2 randomized clinical trial","volume":"4","author":"Heymsfield","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jhepr.2023.100835_bib134","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/postgradmedj-2018-136364","article-title":"Effect of vitamin E in non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomised controlled trials","volume":"95","author":"Amanullah","year":"2019","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.jhepr.2023.100835_bib135","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jhepr.2023.100835_bib136","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1111\/j.1572-0241.2003.08699.x","article-title":"Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis","volume":"98","author":"Harrison","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100835_bib137","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1001\/jama.293.11.1338","article-title":"Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial","volume":"293","author":"Lonn","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jhepr.2023.100835_bib139","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13293-020-00344-1","article-title":"Gender differences in the efficacy of pioglitazone treatment in nonalcoholic fatty liver disease patients with abnormal glucose metabolism","volume":"12","author":"Yan","year":"2021","journal-title":"Biol Sex Differ"},{"key":"10.1016\/j.jhepr.2023.100835_bib140","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1111\/dom.12989","article-title":"Effects of combined low-dose spironolactone plus vitamin E vs vitamin E monotherapy on insulin resistance, non-invasive indices of steatosis and fibrosis, and adipokine levels in non-alcoholic fatty liver disease: a randomized controlled trial","volume":"19","author":"Polyzos","year":"2017","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"10.1016\/j.jhepr.2023.100835_bib141","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF03345529","article-title":"Spironolactone in the treatment of polycystic ovary syndrome: effects on clinical features, insulin sensitivity and lipid profile","volume":"28","author":"Zulian","year":"2005","journal-title":"J Endocrinological Invest"},{"key":"10.1016\/j.jhepr.2023.100835_bib142","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJMoa2028395","article-title":"A placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis","volume":"384","author":"Newsome","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhepr.2023.100835_bib143","first-page":"132","article-title":"Targeting hepatic kisspeptin receptor ameliorates nonalcoholic fatty liver disease in a mouse model","author":"Guzman","year":"2022","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhepr.2023.100835_bib113","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/ageing\/29.3.235","article-title":"Relationships between physical performance measures, age, height and body weight in healthy adults","volume":"29","author":"Samson","year":"2000","journal-title":"Age Ageing"},{"key":"10.1016\/j.jhepr.2023.100835_bib114","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1042\/cs0840095","article-title":"Muscle weakness in women occurs at an earlier age than in men, but strength is preserved by hormone replacement therapy","volume":"84","author":"Phillips","year":"1993","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.jhepr.2023.100835_bib115","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/sj.ejcn.1601198","article-title":"Age-related differences in fat-free mass, skeletal muscle, body cell mass and fat mass between 18 and 94 years","volume":"55","author":"Kyle","year":"2001","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.jhepr.2023.100835_bib116","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.600668","article-title":"The female menstrual cycles effect on strength and power parameters in high-level female team athletes","volume":"12","author":"Dasa","year":"2021","journal-title":"Front Physiol"},{"key":"10.1016\/j.jhepr.2023.100835_bib117","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1113\/EP089962","article-title":"The oestrous cycle and skeletal muscle atrophy: investigations in rodent models of muscle loss","volume":"106","author":"Rosa-Caldwell","year":"2021","journal-title":"Exp Physiol"},{"key":"10.1016\/j.jhepr.2023.100835_bib138","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/jama.2011.1437","article-title":"Vitamin E and the risk of prostate cancer: the selenium and vitamin E cancer prevention trial (SELECT)","volume":"306","author":"Klein","year":"2011","journal-title":"JAMA"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555923001660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555923001660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T04:10:05Z","timestamp":1778904605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555923001660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":142,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S2589555923001660"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2023.100835","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-alcoholic fatty liver disease in women \u2013 Current knowledge and emerging concepts","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2023.100835","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"100835"}}